Patrick A. Lennon
LabCorp (United States)(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Hedgehog Signaling Pathway Studies, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome(2011)246 cited
- → Optical genome mapping in acute myeloid leukemia: a multicenter evaluation(2022)104 cited
- → Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies(2008)96 cited
- → Sonic Hedgehog Signaling Pathway Is Activated in ALK-Positive Anaplastic Large Cell Lymphoma(2009)93 cited
- → Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: Clinical report and review(2007)82 cited
- → Prognostic value of MYC rearrangement in cases of B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and Burkitt lymphoma(2011)73 cited
- → Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia(2007)60 cited
- → Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes(2008)37 cited
- → Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms(2018)35 cited
- → Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group(2018)28 cited